Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Showing 11 to 15 of 15

TitleReference numberPublishedLast updated
Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatmentTA1036
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancerTA1037
Ovarian cancerQS18
Intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary interventionHTG740
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209

Results per page

  1. 10
  2. 25
  3. 50
  4. All